Biocon Biologics’ portfolio of biosimilars includes Denosumab which is used to treat osteoporosis and cancer.
Biocon Biologics’ portfolio of biosimilars includes Denosumab which is used to treat osteoporosis and cancer.
Preclinical
Clinical
Filed
Approved
Launched